The meaning of our business is to make your success, to help you meet your challenges, day after day, year after year. Because beautiful stories are always written together.
Imerys shares its vision for sustainable construction at World of Concrete, the world’s largest concrete industry trade fair.
Sewper® Liner has obtained Imerys’ Pioneer certification, securing its place amongst the Group’s most sustainable solutions. Here are four reasons why.
By launching a project to mine lithium in France, Imerys is playing its part in the energy transition
On October 24, Imerys announced the start of the EMILI project in the presence of government officials, elected representatives and local authorities.
Three-day event marks formal inauguration of Imerys’ milestone calcium aluminate plant in Vizag, India
Since the launch of the first commercial sales a year ago, Imerys’ calcium aluminate plant in Vizag has brought the Group closer to customers in India and is supporting the country’s fast growing economic development.
Representing only 0.1% of global cement usage, calcium aluminate specialty binders are true enablers in the world of construction, allowing builders to save time, boost productivity and leverage many innovations and sustainable options.
The future of construction is sustainable. That future is what Imerys scientists recently exhibited at the Calcined Clays for Sustainable Concrete event in Lausanne, Switzerland with their white paper on low CO2 binder acceleration technology.
Versatile, strong, resistant, long-lasting, mostly natural, chemically inert, easy to clean with hygienic characteristics — it’s easy to see why ceramic products and their applications are so very popular. They are part and parcel of our daily lives, from the roofs above our heads to the tableware we dine from, from the sanitaryware to keep us clean and refreshed to the electrical appliances around us.
Diatomaceous earth has many practical household applications, but is also used for technical purposes in the chemical, agrifoods, cosmetics and pharmaceutical sectors.